Transfusion in the management of patients with megaloblastic anaemia.
Transfusion has been associated with significant morbidity and mortality in megaloblastic anaemia (MA). This retrospective study was undertaken to examine the usefulness of transfusion in the management of MA. Fifty-two patients with MA were identified. Of the 20 transfused patients 13 were treated with diuretics and six with potassium supplements. The mean haemoglobin (Hb) of the transfused group was 6.5 g/dl (range 4.8-10.4 g/dl), and of the 32 non-transfused patients 10.5 g/dl (range 5.6-17.0 g/dl). The Hb and packed cell volume (PCV) were significantly lower in the transfused group. Only two of 32 non-transfused group were given potassium supplements. In this small group of patients with MA, transfusion appeared to be safe and no complications of transfusion were identified. However, advice was not being followed. We would suggest that, although transfusion has a minor role in the management of MA, consideration must be given to the general hazards of transfusion.
McMullin
M F
MF
Department of Haematology, Queen's University of Belfast, Northern Ireland, UK.
Cuthbert
R J
RJ
D000749:Anemia, Megaloblastic / Q000097:blood / Q000628:therapy*; D001803:Blood Transfusion / Q000379:methods*; D004232:Diuretics / Q000627:therapeutic use; D006441:Hemoglobin A / Q000032:analysis; D006801:Humans; D011188:Potassium / Q000627:therapeutic use; D012189:Retrospective Studies
D004232:Diuretics; D006441:Hemoglobin A; D011188:Potassium